Search Medical Condition
Please enter condition
Please choose location

Florissant, Missouri Clinical Trials

A listing of Florissant, Missouri clinical trials actively recruiting patient volunteers.

RESULTS

Found (84) clinical trials

Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Dialysis-dependent Chronic Kidney Disease (DD-CKD)

This is a multicenter, randomized, open-label, active-controlled Phase 3 study of the efficacy and safety of vadadustat versus darbepoetin alfa for the maintenance treatment of anemia in subjects with DD-CKD

Phase

0.0 miles

Learn More »

Iron deficiency anemia (IDA) is most common in patients with cancer, chronic kidney disease, and gastrointestinal diseases such as inflammatory bowel diseases, menstruating or pregnant women, and patients who have undergone gastric bypass surgeries. IDS can have a significant impact on a person's quality of life, so it is important ...

Phase

1.54 miles

Learn More »

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

This is a randomized, double-blind, parallel-group, placebo-controlled, multiple-dose study to assess the efficacy and safety of NYX-2925 in subjects with neuropathic pain associated with diabetic peripheral neuropathy. The study will be a 6 to 9-week study, including a 1-to 4-week (dependent on duration of washout period) Screening Period, followed by ...

Phase

2.45 miles

Learn More »

Efficacy Safety and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Adults

This randomized, observer-blind, placebo-controlled multicenter, Phase 3 study will be conducted at multiple sites. The composition of the Quadrivalent VLP Influenza Vaccine to be used in this study includes a mix of recombinant H1, H3, and two B hemagglutinin proteins expressed as VLPs for the 2017-2018 influenza virus strains. Approximately ...

Phase

3.31 miles

Learn More »

A double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse events

Phase

4.77 miles

Learn More »